Table 1.
Clinical characteristics of COVID-19 patients in this study.
| Characteristic | All patients (N = 50) | Stratified by disease severity |
||
|---|---|---|---|---|
| Asymptomatic/mild (N = 37) | Moderate (N = 10) | Severe/critical (N = 3) | ||
| Age Mean (SD), yr | 40.92 (16.03) | 36.4 (14.04) | 49.28 (14.35) | 68 (3.56) |
| Female Sex – No./total no. (%) | 18/50 (36%) | 16/37 (43.24%) | 1/10 (10%) | 1/3 (33.33%) |
| Body Mass (kg) – Mean (SD) | 66.2 (30.84) | 63.4 (28.65) | 73.07 (41.83) | 77.93 (8.29) |
| Current Smoker – no./total no. (%) | 0/50 (0%) | 0/37 (0%) | 0/10 (0%) | 0/3 (0%) |
| Coexisting Disorder - no./total no. (%) | ||||
| Chronic Cardiac Disease (not Hypertension) | 3/50 (6%) | 1/37 (2.7%) | 2/10 (20%) | 0/3 (0%) |
| Hypertension | 9/50 (18%) | 5/37 (13.51%) | 3/10 (30%) | 1/3 (33.33%) |
| Chronic Pulmonary Disease | 0/50 (0%) | 0/37 (0%) | 0/10 (0%) | 0/3 (0%) |
| Asthma | 0/50 (0%) | 0/37 (0%) | 0/10 (0%) | 0/3 (0%) |
| Chronic kidney disease | 1/50 (2%) | 0/37 (0%) | 0/10 (0%) | 1/3 (33.33%) |
| Chronic liver disease | 0/50 (0%) | 0/37 (0%) | 0/10 (0%) | 0/3 (0%) |
| Chronic Neurological Disorder | 0/50 (0%) | 0/37 (0%) | 0/10 (0%) | 0/3 (0%) |
| Diabetes Mellitus | 8/50 (16%) | 3/37 (8.1%) | 3/10 (30%) | 2/3 (66.66%) |
| Malignant Neoplasms | 0/50 (0%) | 0/37 (0%) | 0/10 (0%) | 0/3 (0%) |